Neurocrine Accessibility Statement
Our Commitment to Digital Accessibility
At Neurocrine Biosciences, our purpose is to relieve patient suffering and enhance lives. This includes offering digital accessibility and providing websites that are easy to find and use by all people. We will conform to the Web Content Accessibility Guidelines (WCAG) 2.1, Level A and AA and comply with the Americans with Disabilities Act (ADA) effective communication requirements, and other applicable regulations.
To accomplish this, we have partnered with eSSENTIAL Accessibility to administer our accessibility program and oversee its governance. Their accessibility program evaluates and audits our digital products on an ongoing basis in accordance with best practices and is supported by a diverse team of accessibility professionals, including users of assistive technologies. The platform, moreover, goes beyond minimum compliance requirements by making an assistive CX technology application available to customers who have trouble typing, gesturing, moving a mouse, or reading. The application is free to download and it incorporates tools such as mouse and keyboard replacements, voice recognition, speech enablement, hands-free/touch-free navigation, and more.
How to Use
When you select a link from our web pages, which leads to a third party managed website, you are subject to the privacy, copyright, security, and information quality policies of that website, and we cannot guarantee that the website will comply with the accessibility requirements of Section 508 of the Rehabilitation Act and the Web Content Accessibility Guidelines (WCAG).
We welcome any feedback and want to address any questions or concerns if you have trouble getting to or using any page on our website or any of our digital properties. Please contact our Customer Support at 1 (844) 464-7399 or Compliance@neurocrine.com